• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Colorectal Cancer Statistics From the American Cancer Society

A new study from the American Cancer Society shows colorectal cancer rates have been shifting towards younger patients and advanced stages. In 2019, the number of people diagnosed with advanced colon cancer nearly doubled, and people under 55, the rate of being diagnosed also increase from 11 percent to 20%.

Incidence

Since the mid-1980s, there has been a decline in colorectal cancer mainly due to more people have been taken to be screened. However, the incidence has been increasing for adults younger than 50 since 2014 (see Figure 1).

Colorectal Cancer is the fourth leading cause of death from cancer for men and women aged 30 to 39. In 2019, there were estimated 106,970 new cases of Colon cancer lawsuit settlement and rectal cancer in the United States, with about 37,000 deaths caused by this disease.

Around 4.1 percent of men and 3.6 percent of women will be diagnosed with colon or rectal cancer during their lifetime. These statistics are based upon population estimates from the National Cancer Institute's Surveillance Epidemiology and End Results Program as well as the Centers for Disease Control and Prevention’s National Program of Cancer Registries.

Incidence rates are per 100,000 population and are adjusted according to age in the 2000 US standard population. Rates exclude appendiceal cancer.

The rate of colorectal carcinoma is different based on race/ethnicity and Cancer Colon cancer gender. It is more common for black people than whites, and is less common among Asian Americans. The rates are higher among minority groups due to the fact that less than half of them have been screened and are more at risk for developing risk factors like having a family CRC history, or prior history polyps, or inflammatory diseases.

Mortality

The mortality rate for colon and rectal carcinoma is continuing to decrease in part due to improvements in screening and treatment. The rate of improvement has slowed down after 2010, and mortality rates in a few groups have increased somewhat. The risk of advanced-stage cancer has risen among people older than 50 compared with the mid-2000s, and the rates are shifting to left-sided tumors. The increase in advanced-stage diagnoses and the shift to left-sided tumors has occurred despite greater effectiveness for the treatment of these tumors through screening.

The mortality rates differ greatly depending on race, age or ethnicity. Since 2005, the difference between Blacks and Whites has declined significantly, while Hispanics and non-Hispanic Whites have remained stable. Additionally, racial disparities persist for the most frequent subsites of the disease and the overall disease.

ACS CAN is committed to continuing to work with partners to raise awareness of the importance of screening for CRC and encourage everyone who is eligible to participate in routine screening. ACS CAN also works to promote policies that remove obstacles to screening, for example making sure that Medicare patients are covered for colonoscopies to follow-up after non-invasive screening tests, without cost sharing and lowering screening age to 45. These policies can aid in improving the availability of early detection and treatment, and, consequently, help prevent colorectal cancer deaths.

Screening

A large number of colorectal cancers are identified through screening procedures. These tests look for small cancerous polyps, which could bleed tiny amounts blood, and can find early-stage colon cancer before it develops any symptoms. These tests are called screening because they can help in preventing Colon cancer injury cancer or detect it at a point when it is easier to treat.

The first step in screening for colorectal carcinoma is usually stool tests. These tests look for evidence in the stool of blood derived from cancerous polyps or tumors that are still in an early stage. Regular screening is the best way to identify these stains.

Certain individuals are at greater risk for colorectal cancer than others due to a family history of the disease, or have an illness that increases the chances of developing it. For instance, those with inflammatory bowel diseases like ulcerative colitis or Crohn's disease are more prone to developing colon cancer because these conditions can cause inflammation in the colon lining. People with certain genetic conditions like Lynch syndrome or familial adenomatous polyposis are also at higher risk. These people need to begin colon cancer screenings (colonoscopy or stool tests) earlier and more frequently than those who don't have an ancestral history of colon cancer.

Roswell Park recommends that people at risk of being average to begin routine screening for colon cancer at the age of 50. They should discuss the matter with their doctor and, based on their risk, consider the possibility of a younger age range.

Prevention

There are certain people who have a higher chance of colon cancer than other people. A family history of colon cancer or polyps may increase your risk. This includes your parents as well as siblings and children who are males; having a previous abdominal surgery; and age and race/ethnicity.

Regularly screening for colorectal cancer may help prevent the disease. A sigmoidoscopy and Cancer colon Cancer colonoscopy are generally recommended for people over 50, but you should start screening before the age of 50 if there is a a personal or family history of colon Cancer Colon Cancer or inflammatory bowel disease such as Crohn's disease or ulcerative colitis.

Talk to your doctor if you see blood or dark red stool. The blood in your stool could be caused by a variety of things however it's crucial to have it checked out.

If you're at a high risk of developing Colon cancer settlement cancer you may reduce your chances by eating a healthy diet and exercising. Also, you should not smoke or drink excessively. use. People who are female and AMAB are advised to limit their alcohol consumption to one serving per day.